Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Su, Xi
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)	Active, not recruiting	N/A	539	RoW	BuMA Supreme, BuMA™	Sino Medical Sciences Technology Inc.	Coronary Artery Disease	03/18	12/25
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)	Active, not recruiting	N/A	1000	RoW	BuMA Supreme	Sino Medical Sciences Technology Inc.	Coronary Artery Disease	05/19	12/25
NCT04569669: The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis	Not yet recruiting	N/A	325	RoW	FFR and FFRCT	CCRF Inc., Beijing, China, Shengshi Technology, Co., Ltd, Hangzhou, China	Coronary Stenosis	10/21	03/22
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis	Completed	N/A	260	RoW	drug-coated balloon Catheter	B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China	Coronary Artery Disease, In Stent Restenosis	07/22	08/22
BEYOND-II, NCT03820622: The Safety and Efficacy of DIOR Balloon in Coronary Bifurcation Lesions	Not yet recruiting	N/A	220	RoW	Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo)	CCRF Inc., Beijing, China	Percutaneous Coronary Intervention	05/22	10/22
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction	Recruiting	N/A	250	RoW	Dexmedetomidine (DEX), Placebo (Saline)	Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd.	ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection	12/24	12/25
NCT05375110: NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)	Recruiting	N/A	120	RoW	NoYAâ„¢ Radiofrequency Interatrial Shunt System	Hangzhou NOYA MedTech Co. Ltm.	Heart Failure	12/22	12/23